New development and application of ultrasound targeted microbubble destruction in gene therapy and drug delivery

Current Gene Therapy

Volumn 13, Issue 4, 2013, Pages 250-274

  Chen, Zhi Yi ^a   Yang, Feng ^a   Lin, Yan ^a   Zhang, Jin Shan ^a   Qiu, Ri Xiang ^a   Jiang, Lan ^a   Zhou, Xing Xing ^a   Yu, Jiang Xiu ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Application; Drug delivery; Gene therapy; Microbubble; Ultrasound

Indexed keywords

8 QUINOLINOL INDIUM IN 111; ABCIXIMAB; ANTISENSE OLIGONUCLEOTIDE; BLEOMYCIN; CONNECTIVE TISSUE GROWTH FACTOR; DOXORUBICIN; FIBRINOLYTIC AGENT; FLUORESCEIN ISOTHIOCYANATE; FUMAGILLOL CHLOROACETYLCARBAMATE; GADOLINIUM; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTIVIRUS VECTOR; LIPOSOME; NANOPARTICLE; NAVELBINE; PACLITAXEL; POLYMER; RADIOPHARMACEUTICAL AGENT; RETROVIRUS VECTOR; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UROKINASE; VASCULOTROPIN 165; VIRUS VECTOR;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; IRRADIATION; MESENCHYMAL STEM CELL; MICROBUBBLE; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; MULTIDRUG RESISTANCE; NEOPLASM; NONHUMAN; PERITONEAL DIALYSIS; PHYSICAL CHEMISTRY; RNA INTERFERENCE; TUMOR XENOGRAFT; ULTRASOUND TARGETED MICROBUBBLE DESTRUCTION; ULTRASOUND THERAPY;

DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; MICROBUBBLES; ULTRASONICS; ULTRASONOGRAPHY;

EID: 84888080829     PISSN: 15665232     EISSN: 18755631     Source Type: Journal    
DOI: 10.2174/15665232113139990003     Document Type: Article

References (141)

1. Deshpande N, Needles A, Willmann JK. Molecular ultrasound imaging: current status and future directions. Clin Radiol 2010; 65(7): 567-581.
2. Delalande A, Postema M, Mignet N, Midoux P, Pichon C. Ultrasound and microbubble-assisted gene delivery: recent advances and ongoing challenges. Ther Deliv 2012; 3(10): 1199-1215.
3. Chen ZY, Liang K, Liu J, et al. Enhancement of survivin gene downregulation and cell apoptosis by a novel combination: liposome microbubbles and ultrasound exposure. Med Oncol 2009; 26(4): 491-500.
4. Geis NA, Katus HA, Bekeredjian R. Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des 2012, 18(15): 2166-2183.
5. Kiessling F, Fokong S, Koczera P, Lederle W, Lammers T. Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med 2012; 53(3): 345-348.
6. Chen ZY, Liang K, Qiu RX, Luo LP. Ultrasound and liposome microbubbles mediated targeted gene transfer to cardiomyocytes in vivo accompanied with polyethylenimine. J Ultrasound Med 2011; 30(9): 1247-1258.
7. Taniyama Y, Tachibana K, Hiraoka K, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105(10): 1233-1239.
8. Taniyama Y, Tachibana K, Hiraoka K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002; 9(6): 372-380.
9. Suzuki R, Oda Y, Utoguchi N, Maruyama K. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano and microbubbles. J Control Release 2011; 149(1): 36-41.
10. Liang HD, Tang J, Halliwell M. Sonoporation, drug delivery, and gene therapy. Proc Inst Mech Eng H 2010; 224(2): 343-361.
11. Kimmel E. Cavitation bioeffects. Crit Rev Biomed Eng 2006; 34(2): 105-61.
12. Tinkov S, Bekeredjian R, Winter G, Coester C. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci 2009; 98(6): 1935-1961.
13. Mayer CR, Geis NA, Katus HA, Bekeredjian R. Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin Drug Deliv 2008; 5(10): 1121-1138.
14. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007; 9: 415-447.
15. Fechheimer M, Boylan JF, Parker S, Sisken JE, Patel GL, Zimmer SG. Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci USA 1987; 84(23): 8463-8467.
16. Kim HJ, Greenleaf JF, Kinnick RR, Bronk JT, Bolander ME. Ultrasound mediated transfection of mammalian cells. Hum Gene Ther 1996; 7(11): 1339-1346
17. Bao S, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol 1997; 23(6): 953-959.
18. Greenleaf WJ, Bolander ME, Sarkar G, Goldring MB, Greenleaf JF. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 1998; 24(4): 587-589.
19. Liang HD, Lu QL, Xue SA, et al. Optimisation of ultrasoundmediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med Biol 2004; 30(11): 1523-1529.
20. Zarnitsyn VG, Prausnitz MR. Physical parameters influencing optimization of ultrasound-mediated DNA transfection. Ultrasound Med Biol 2004; 30(4): 527-538.
21. Kinoshita M, Hynynen K. A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. Biochem Biophys Res Commun 2005; 335(2): 393-399.
22. Pan H, Zhou Y, Izadnegahdar O, Cui J, Deng CX. Study of sonoporation dynamics affected by ultrasound duty cycle. Ultrasound Med Biol 2005; 31(6): 849-856.
23. Fang HY, Tsai KC, Cheng WH, et al. The effects of power on-off durations of pulsed ultrasound on the destruction of cancer cells. Int J Hyperthermia 2007; 23(4): 371-380.
24. Duvshani-Eshet M, Adam D, Machluf M. The effects of albumincoated microbubbles in DNA delivery mediated by therapeutic ultrasound. J Control Release 2006; 112(2): 156-166.
25. Fischer AJ, Stanke JJ, Omar G, Askwith CC, Burry RW. Ultrasoundmediated gene transfer into neuronal cells. J Biotechnol 2006; 122(4): 393-411.
26. Lee YH, You JO, Peng CA. Retroviral Transduction of Adherent Cells in Resonant Acoustic Fields. Biotechnol Prog 2005; 21(2): 372-376.
27. Amarzguioui M. Improved siRNA-mediated silencing in refractory adherent cell lines by detachment and transfection in suspension. Biotechniques 2004; 36(5): 766-768, 770.
28. Duvshani-Eshet M, Baruch L, Kesselman E, Kesselman E, Shimoni E, Machluf M. Therapeutic ultrasound-mediated DNA to cell and nucleus: bioeffects revealed by confocal and atomic force microscopy. Gene Ther 2006; 13(2): 163-172.
29. Ohl CD, Arora M, Ikink R, et al. Sonoporation from Jetting Cavitation Bubbles. Biophysical J, 2006, 91(11): 4285-4295.
30. Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC, Newman CM. Microbubble enhanced ultrasound for vascular gene therapy. Gene Ther 2000; 7(23): 2023-2027.
31. Sakakima Y, Hayashi S, Yagi Y, Hayakawa A, Tachibana K, Nakao A. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther 2005; 12(11): 884-889.
32. Wang X, Liang HD, Dong B, Lu QL, Blomley MJ. Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: Comparison between commercially available microbubble contrast agents. Radiology 2005; 237(1): 224-229.
33. Meijering BD, Henning RH, Van Gilst WH, Gavrilovic I, Van Wamel A, Deelman LE. Optimization of ultrasound and microbubbles targeted gene delivery to cultured primary endothelial cells. J Drug Target 2007; 15(10): 664-671.
34. Larina IV, Evers BM, Esenaliev RO. Optimal drug and gene delivery in cancer cells by ultrasound-induced cavitation. Anticancer Res 2005; 25(1A): 149-156.
35. Tinkova S, Bekeredjianb R, Wintera G, Coester C. Characterization of ultrasound-mediated destruction of drug-loaded microbubbles using an improved in vitro model. Appl Acoust 2009; 70(10): 1323-1329.
36. Li T, Tachibana K, Kuroki M, Kuroki M. Gene transfer with echoenhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice-initial results. Radiology 2003; 229(2): 423-428.
37. Akowuah EF, Gray C, Lawrie A, et al. Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model. Gene Ther 2005; 12(14): 1154-1157.
38. Pislaru SV, Pislaru C, Kinnick RR, et al. Optimization of ultrasound mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur Heart J 2003; 24(18): 1690-1698.
39. Zhao YZ, Luo YK, Tang J, Zhang Y, Lin Q, Mei XG. Comparison of sonoporation effect of liposomes and phospholipids-based microbubbles on cultured cell membrane. Yao Xue Xue Bao 2006; 41(12): 1176-1179. Article in Chinese.
40. Klibanov AL, Shevchenko TI, Raju BI, Seip R, Chin CT. Ultrasound triggered release of materials entrapped in microbubbleliposome constructs: a tool for targeted drug delivery. J Control Release 2010; 148(1): 13-17.
41. Nomikou N, McHale AP. Microbubble-enhanced ultrasoundmediated gene transfer-towards the development of targeted gene therapy for cancer. Int J Hyperthermia 2012; 28(4): 300-310.
42. Duvshani-Eshet M, Machluf M. Therapeutic ultrasound optimization for gene delivery: a key factor achieving nuclear DNA localization. J Control Release 2005; 108(2-3): 513-528.
43. Zarnitsyn VG, Prausnitz MR. Physical parameters influencing optimization of ultrasound -mediated DNA transfection. Ultrasound Med Biol 2004; 30(4): 527-538.
44. Meijering BD, Henning RH, Van Gilst WH, Gavrilovic I, Van Wamel A, Deelman LE. Optimization of ultrasound and microbubbles targeted gene delivery to cultured primary endothelial cells. J Drug Target 2007; 15(10): 664-671.
45. Feril LB Jr, Ogawa R, Tachibana K, Kondo T. Optimized ultrasound mediated gene transfection in cancer cells. Cancer Sci 2006; 97(10): 1111-1114.
46. Shen ZP, Brayman AA, Chen L, Miao CH. Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery. Gene Ther 2008; 15(16): 1147-1155.
47. Ng KY, Liu Y. Therapeutic ultrasound: its application in drug delivery. Med Res Rev 2002; 22 (2): 204-223.
48. Feril LB Jr, Kondo T. Biological effects of low intensity ultrasound: the mechanism involved, and its implications on therapy and on biosafety of ultrasound. J Radiat Res (Tokyo) 2004; 45(4): 479-489.
49. Vancraeynest D, Havaux X, Pasquet A, et al. Myocardial injury induced by ultrasound-targeted microbubble destruction: Evidence for the contribution of myocardial ischemia. Ultrasound Med Biol 2009; 35(4): 672-679.
50. Miller DL, Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci USA 2000; 97(18): 10179-10184.
51. Miller DL. Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation. Prog Biophys Mol Biol 2007; 93(1-3): 314-330
52. Chen S, Ding JH, Bekeredjian R, et al. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci USA 2006; 103(22): 8469-8474.
53. Taylor SL, Rahim AA, Bush NL, Bamber JC, Porter CD. Targeted retroviral gene delivery using ultrasound. J Gene Med 2007; 9(2): 77-87.
54. Howard CM, Forsberg F, Minimo C, Liu JB, Merton DA, Claudio PP. Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. J Cell Physiol 2006; 209(2): 413-421.
55. Koch S, Pohl P, Cobet U, Rainov NG. Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects. Ultrasound Med Biol 2000; 26(5): 897-903.
56. Un K, Kawakami S, Yoshida M, et al. The elucidation of gene transferring mechanism by ultrasound-responsive unmodified and mannose-modified lipoplexes. Biomaterials 2011; 32(20): 4659-4669.
57. Vancraeynest D, Havaux X, Pouleur AC, et al. Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction. Eur Heart J 2006; 27(2): 237-245.
58. Yang F, Zhang M, He W, et al. Controlled release of Fe3O4 nanoparticles in encapsulated microbubbles to tumor cells via sonoporation and associated cellular bioeffects. Small 2011; 7(7): 902-910.
59. Burke CW, Hsiang YH, Alexander E 4th, Kilbanov AL, Price RJ. Covalently linking poly(lactic-co-glycolic acid) nanoparticles to microbubbles before intravenous injection improves their ultrasound targeted delivery to skeletal muscle. Small 2011; 7(9): 1227-1235.
60. Tiera MJ, Shi Q, Winnik FM, et al. Polycation-based gene therapy: current knowledge and new perspectives. Curr Gene Ther 2011; 11(4): 288-306.
61. Delalande A, Postema M, Mignet N, Midoux P, Pichon C. Ultrasound and microbubble-assisted gene delivery: recent advances and ongoing challenges. Ther Deliv 2012; 3(10): 1199-1215.
62. Chumakova OV, Liopo AV, Andreev VG, et al. Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett 2008; 261(2): 215-225.
63. Lee YH, Peng CA. Nonviral transfection of suspension cells in ultrasound standing wave fields. Ultrasound Med Biol 2007 33(5): 734-742.
64. Chen YC, Jiang LP, Liu NX, et al. Enhanced gene transduction into skeletal muscle of mice in vivo with pluronic block copolymers and ultrasound exposure. Cell Biochem Biophys 2011; 60(3): 267-273.
65. Saini R, Warram JM, Sorace AG, et al. Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents. Ultrasound Med Biol 2011; 37(8): 1306-1313.
66. Khare R, Chen CY, Weaver EA, et al. Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 2011; 11(4): 241-258.
67. Guo Z, Hong S, Jin X, Luo Q, Wang Z, Wang Y. Study on the multidrug resistance 1 gene transfection efficiency using adenovirus vector enhanced by ultrasonic microbubbles in vitro. Mol Biotechnol 2011; 48(2): 138-146.
68. Lee YH, Peng CA. Enhanced retroviral gene delivery in ultrasonic standing wave fields. Gene Ther 2005; 12(7): 625-633.
69. Zheng XZ, Wu Y, Li HL, Du LF, Gu Q, Wang HP. Comparative analysis of the effects of ultrasound-targeted microbubble destruction on the recombinant adeno-associated virus and plasmid mediated transgene expression in human retinal pigment epithelium cell. Mol Med Rep 2009; 2: 937-942.
70. Mannell H, Pircher J, Räthel T, et al. Targeted endothelial gene delivery by ultrasonic destruction of magnetic microbubbles carrying lentiviral vectors. Pharm Res 2012; 29(5): 1282-1294.
71. Sheikov N, McDannold N, Jolesz F, Zhang YZ, Tam K, Hynynen K. Brain arterioles show more active vesicular transport of bloodborne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound Med Biol 2006; 32(9): 1399-1409.
72. Vandenbroucke RE, Lentacker I, Demeester J, De Smedt SC, Sanders NN. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles. J Control Release 2008; 126(3): 265-273.
73. Li YH, Shi QS, Du J, et al. Targeted delivery of biodegradable nanoparticles with ultrasound-targeted microbubble destructionmediated hVEGF-siRNA transfection in human PC-3 cells in vitro. Int J Mol Med 2013; 31(1): 163-171.
74. Saito M, Mazda O, Takahashi KA, et al. Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo. J Orthop Res 2007; 25(10): 1308-1316.
75. Carson AR, McTiernan CF, Lavery L, et al. Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Res 2012; 72(23): 6191-6199.
76. Zheng X, Du L, Wang H, Gu Q. A novel approach to attenuate proliferative vitreoretinopathy using ultrasound-targeted microbubble destruction and recombinant adeno-associated virus-mediated RNA interference targeting transforming growth factor-_2 and platelet-derived growth factor-B. J Gene Med 2012; 14(5): 339-347.
77. Han X, Cheng W, Jing H, Zhang JW, Tang LL. Neuroepithelial transforming protein 1 short interfering RNA-mediated gene silencing with microbubble and ultrasound exposure inhibits the proliferation of hepatic carcinoma cells in vitro. J Ultrasound Med 2012; 31(6): 853-861.
78. Burgess A, Huang Y, Querbes W, Sah DW, Hynynen K. Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. J Control Release 2012; 163(2): 125-129.
79. Endo-Takahashi Y, Negishi Y, Kato Y, Suzuki R, Maruyama K, Aramaki Y. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound. Int J Pharm 2012; 422(1-2): 504-509.
80. Otani K, Yamahara K, Ohnishi S, Obata H, Kitamura S, Nagaya N. Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasound and microbubbles. J Control Release 2009; 133(2): 146-153.
81. Tsunoda S, Mazda O, Oda Y, et al. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun 2005; 336(1): 118-127.
82. Porter TR, Iversen PL, Li S, Xie F. Interaction of diagnostic ultrasound with synthetic oligonucleotide labeled perfluorocarbon exposed sonicated dextrose albumin microbubbles. J Ultrasound Med 1996; 15(8): 577-584.
83. Bekeredjian R, Chen S, Frenkel PA, Grayburn PA, Shohet RV. Ultrasound targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003; 108 (8): 1022-1026.
84. Chen SY, Shohet RV, Bekeredjian R, Frenkel P, Grayburn PA. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. JACC 2003; 42(2): 301-308.
85. Zen K, Okigaki M, Hosokawa Y, et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol 2006; 40(6): 799-809.
86. Iwasaki M, Adachi Y, Nishiue T, et al. Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in doxorubicin-induced cardiomyopathy. Stem Cells 2005; 23 (10): 1589-1597.
87. Bekeredjian R, Chen S, Pan W, Grayburn PA, Shohet RV. Effects of ultrasound targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol 2004; 30(4): 539-543.
88. Vannan M, McCreery T, Li P, et al. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J Am Soc Echocardiogr 2002; 15(3): 214-218.
89. Ji J, Ji SY, Yang JA, et al. Ultrasound-targeted transfection of tissue-type plasminogen activator gene carried by albumin nanoparticles to dog myocardium to prevent thrombosis after heart mechanical valve replacement. Int J Nanomedicine 2012; 7: 2911-2919.
90. Xu YL, Gao YH, Liu Z, et al. Myocardium-targeted transplantation of mesenchymal stem cells by diagnostic ultrasound-mediated microbubble destruction improves cardiac function in myocardial infarction of New Zealand rabbits. Int J Cardiol 2010; 138(2): 182-195.
91. Hallow DM, Mahajan AD, Prausnitz MR. Ultrasonically targeted delivery into endothelial and smooth muscle cells in ex vivo arteries. J Control Release 2007; 118(3): 285-293.
92. Kodama T, Tan PH, Offiah I, et al. Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles. Ultrasound Med Biol 2005; 31 (12): 1683-1691.
93. Beeri R, Guerrero JL, Supple G, Sullivan S, Levine RA, Hajjar RJ. New efficient catheter-based system for myocardial gene delivery. Circulation 2002; 106(14): 1756-1759.
94. Imada T, Tatsumi T, Mori Y, et al. Targeted delivery of bone marrow mononuclear cells by ultrasound destruction of microbubbles induces both angiogenesis and arteriogenesis response. Arterioscler Thromb Vasc Biol 2005; 25(10): 2128-2134.
95. Hashiya N, Aoki M, Tachibana K, et al. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem Biophys Res Commun 2004; 317(2): 508-514.
96. Phillips LC, Klibanov AL, Wamhoff BR, Hossack JA. Targeted gene transfection from microbubbles into vascular smooth muscle cells using focused, ultrasound-mediated delivery. Ultrasound Med Biol 2010; 36(9): 1470-1480.
97. Duvshani-Eshet M, Machluf M. Efficient transfection of tumors facilitated by long-term therapeutic ultrasound in combination with contrast agent: from in vitro to in vivo setting. Cancer Gene Ther 2007; 14(3): 306-315.
98. Huber PE, Pfisterer P. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther 2000; 7(17): 1516-1525.
99. Anwer K, Kao G, Proctor B, et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther 2000; 7(21): 1833-1839.
100. Hosseinkhani H, Tabata Y. Ultrasound enhances in vivo tumor expression of plasmid DNA by PEG -introduced cationized dextran. J Control Release 2005; 108: 540-556.
101. Hauff P, Seemann S, Reszka R, et al. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology 2005; 236(2): 572-578.
102. Reynolds AR, Moein Moghimi S, Hodivala Dilke K. Nanoparticle mediated gene delivery to tumor neovasculature. Trends Mol Med 2003; 9(1): 2-4.
103. Guo H, Leung JC, Lam MF, et al. Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis. J Am Soc Nephrol 2007; 18(10): 2689-2703.
104. Sun Y, Zhu F, Yu X, et al. Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis. Am J Nephrol 2009; 30(1): 84-94.
105. Koike H, Tomita N, Azuma H, et al. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 2005; 7(1): 108-116.
106. Ka SM, Huang XR, Lan HY, et al. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol 2007; 18(6):1777-1778.
107. Chung AC, Zhang H, Kong YZ, et al. Advanced glycation endproducts induce tubular CTGF via TGF beta independent Smad3 signaling. J Am Soc Nephrol 2010; 21(2): 249-260.
108. Azuma H, Tomita N, Kaneda Y, et al. Transfection of NF kappa Bdecoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 2003; 10(5): 415-425.
109. Manome Y, Nakayama N, Nakayama K, Furuhata H. Insonation facilitates plasmid DNA transfection into the central nervous system and microbubbles enhance the effect. Ultrasound Med Biol 2005; 31(5): 693-702.
110. Shimamura M, Sato N, Taniyama Y, et al. Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles. J Gene Med 2005; 7(11): 1468-1474.
111. Shimamura M, Sato N, Taniyama Y, et al. Development Of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound. Gene Ther 2004; 11(20): 1532-1539.
112. Schratzberger P, Krainin JG, Schratzberger G, et al. Transcutaneous ultrasound augments naked DNA transfection of skeletal muscle. Mol Ther 2002; 6(5): 576-583.
113. Leong-Poi H, Kuliszewski MA, Lekas M, et al. Therapeutic arteriogenesis by ultrasound -mediatedVEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res 2007; 101(3): 295-303.
114. Kusumanto YH, Mulder NH, Dam WA, et al. Improvement of in vivo transfer of plasmid DNA in muscle: comparison of electroporation versus ultrasound. Drug Deliv 2007; 14(5): 273-277.
115. Anthony D, Michel-Francis B, Patrick M, Bouakaz A, Pichon C. Ultrasound-assisted microbubbles gene transfer in tendons for gene therapy. Ultrasonics 2010; 50(2): 269-272.
116. Negishi Y, Matsuo K, Endo-Takahashi Y, et al. Delivery of an angiogenic gene into ischemic muscle by novel bubble liposomes followed by ultrasound exposure. Pharm Res 2011; 28(4): 712-719.
117. Burke CW, Suk JS, Kim AJ, et al. Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles. J Control Release 2012; 162(2): 414-421.
118. Xenariou S, Griesenbach U, Liang HD, et al_Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther 2007; 14(9): 768-774.
119. Endoh M, Koilbuchi N, Sato M, et al. Fetal gene transfer by intrauterine injection with microbubble enhanced ultrasound. Mol Ther 2002; 5(5): 501-508.
120. Sonoda S, Tachibana K, Uchino E, et al. Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Invest Ophthalmol Vis Sci 2006; 47(2): 558-564.
121. Luo J, Zhou X, Diao L, Wang Z. Experimental research on wildtype p53 plasmid transfected into retinoblastoma cells and tissues using an ultrasound microbubble intensifier. J Int Med Res 2010; 38(3): 1005-1015
122. Li T, Liu Z. Ablation of benign prostatic hyperplasia using microbubble mediated ultrasound cavitation. Med Hypotheses 2010; 74(4): 679-680.
123. Bekeredjian R, Kuecherer HF, Kroll RD. Ultrasound-targeted microbubble destruction augments protein delivery into testes. Urology 2007; 69(2): 386-389.
124. Chen S, Ding J, Yu C, Wood DR, Grayburn PA. Reversal of streptozotocin induced diabetes in rats by gene therapy with betacellulinand pancreatic duodenal homeobox-1. Gene Ther 2007 14(14): 1102-1110.
125. Emoto M, Tachibana K, Iwasaki H, Kawarabayashi T. Antitumor effect of TNP-470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color Doppler ultrasound. Cancer Sci 2007; 98(6): 929-935.
126. Sonoda S, Tachibana K, Uchino E, et al. Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 2007; 6(8): 1276-1283.
127. Azuma TM, Kido K, Aoi A, Furukawa H, Ono M, Kodama T. Spinal gene transfer using ultrasound and microbubbles. J Control Release 2007; 117(2): 267-272.
128. Yoshida T, Kondo T, Ogawa R, et al. Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells. Cancer Chemother Pharmacol 2008; 61(4): 559-567.
129. Rapoporta N, Gao Z, Kennedy A. Multifunctional Nanoparticles for Combining Ultrasonic Tumor Imaging and Targeted Chemotherapy. J Natl Cancer Inst 2007; 99(14): 1095-1106.
130. Yan F, Li X, Jin Q, et al. Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells. Ultrasound Med Biol 2011; 37(5): 768-779
131. Liu WS, Huang ZZ, Wang XW, Zhou J. Effects of microbubbles on transcranial Doppler ultrasound -assisted intracranial urokinase thrombolysis. Thromb Res 2012; 130(3): 547-551.
132. Alonso A, Martina AD, Stroick M, et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke 2007; 38: 1508-1514.
133. Xie F, Everbach EC, Gao S, et al. Effects of attenuation and thrombus age on the success of ultrasound and microbubblemediated thrombus dissolution. Ultrasound Med Biol 2011; 37(2): 280-288.
134. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005; 2(1): 3-14.
135. Mesiwala AH, Farrell L, Wenzel HJ, et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med Biol 2002; 28(3): 389-400.
136. L O'Reilly MA, Waspe AC, Ganguly M, Hynynen K. Focusedultrasound disruption of the blood-brain barrier using closely-timed short pulses: influence of sonication parameters and injection rate. Ultrasound Med Biol 2011; 37(4): 587-594.
137. Jordão JF, Ayala-Grosso CA, Markham K, et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease. PLoS One 2010; 5(5): e10549.
138. Yang FY, Wong TT, Teng MC, et al. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J Control Release 2012; 160(3): 652-658.
139. Castro CI, Briceno JC. Perfluorocarbon-based oxygen carriers: review of products and trials. Artif Organs 2010; 34(8): 622-634.
140. Kwan JJ, Borden MA. Lipid monolayer collapse and microbubble stability. Adv Colloid Interface Sci 2012; 183-184: 82-99.
141. Swanson EJ, Mohan V, Kheir J, Borden MA. Phospholipidstabilized microbubble foam for injectable oxygen delivery. Langmuir 2010; 26(20): 15726-15729.